Administration on Intellectual and Developmental Disabilities, President's Committee for People With Intellectual Disabilities, 58775 [2018-25375]

Download as PDF Federal Register / Vol. 83, No. 225 / Wednesday, November 21, 2018 / Notices Board of Governors of the Federal Reserve System, November 15, 2018. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2018–25338 Filed 11–20–18; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living Administration on Intellectual and Developmental Disabilities, President’s Committee for People With Intellectual Disabilities Administration for Community Living, HHS. ACTION: Notice. AGENCY: The President’s Committee for People with Intellectual Disabilities (PCPID) will host a webinar/conference call for its members to discuss the potential topics of the Committee’s 2019 Report to the President. All the PCPID meetings, in any format, are open to the public. This virtual meeting will be conducted in a discussion format. DATES: Webinar/Conference Call: Wednesday, December 5, 2018 from 9:00 a.m. to 10:00 a.m. (EST). FOR FURTHER INFORMATION CONTACT: Ms. Allison Cruz, Director, Office of Innovation, 330 C Street SW, Switzer Building, Room 1114, Washington, DC 20201. Telephone: 202–795–7334. Fax: 202–795–7334. Email: Allison.Cruz@ acl.hhs.gov. SUMMARY: The purpose of this virtual meeting is to discuss the Committee’s preparation of the PCPID 2019 Report to the President, including its content and format, and related data collection and analysis required to complete the writing of the Report. Webinar/Conference Call: The webinar/conference call is scheduled for Wednesday, December 5, 2018, 9:00 a.m. to 10:00 a.m. (EST) and may end early if discussions are finished. Instructions to Participate in the Webinar/Conference Call on Wednesday, December 5, 2018: Please dial: (888) 949–2790; Pass Code: 1989852 Background Information on the Committee: The PCPID acts in an advisory capacity to the President and the Secretary of Health and Human Services on a broad range of topics relating to programs, services and support for individuals with intellectual disabilities. The PCPID executive order stipulates that the Committee shall: (1) khammond on DSK30JT082PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 16:08 Nov 20, 2018 Jkt 247001 Provide such advice concerning intellectual disabilities as the President or the Secretary of Health and Human Services may request; and (2) provide advice to the President concerning the following for people with intellectual disabilities: (A) Expanding employment opportunities; (B) connecting people to services; (C) supporting families and caregivers; (D) strengthening the networks; and (E) protecting rights and preventing abuse. Dated: November 15, 2018. Julie Hocker, Commissioner, Administration on Disabilities (AoD). [FR Doc. 2018–25375 Filed 11–20–18; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2018–N–3522] Use of the Names of Dairy Foods in the Labeling of Plant-Based Products; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. The Food and Drug Administration (FDA or we) is extending the comment period for the notice that appeared in the Federal Register of September 28, 2018. In the notice, FDA invited interested parties to provide information on specific topics related to the labeling of plant-based products with names that include the names of dairy foods such as ‘‘milk,’’ ‘‘cultured milk,’’ ‘‘yogurt,’’ and ‘‘cheese.’’ We are extending the comment period to give interested parties more time to comment. DATES: FDA is extending the comment period on the notice published in the Federal Register of September 28, 2018 (83 FR 49103). Submit either electronic or written comments by January 28, 2019. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before January 28, 2019. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of January 28, 2019. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery SUMMARY: PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 58775 service acceptance receipt is on or before that date. Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2018–N–3522 for ‘‘Use of the Names of Dairy Foods in the Labeling of PlantBased Products.’’ Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two E:\FR\FM\21NON1.SGM 21NON1

Agencies

[Federal Register Volume 83, Number 225 (Wednesday, November 21, 2018)]
[Notices]
[Page 58775]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25375]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Community Living


Administration on Intellectual and Developmental Disabilities, 
President's Committee for People With Intellectual Disabilities

AGENCY: Administration for Community Living, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The President's Committee for People with Intellectual 
Disabilities (PCPID) will host a webinar/conference call for its 
members to discuss the potential topics of the Committee's 2019 Report 
to the President. All the PCPID meetings, in any format, are open to 
the public. This virtual meeting will be conducted in a discussion 
format.

DATES: Webinar/Conference Call: Wednesday, December 5, 2018 from 9:00 
a.m. to 10:00 a.m. (EST).

FOR FURTHER INFORMATION CONTACT: Ms. Allison Cruz, Director, Office of 
Innovation, 330 C Street SW, Switzer Building, Room 1114, Washington, 
DC 20201. Telephone: 202-795-7334. Fax: 202-795-7334. Email: 
[email protected].

SUPPLEMENTARY INFORMATION:  The purpose of this virtual meeting is to 
discuss the Committee's preparation of the PCPID 2019 Report to the 
President, including its content and format, and related data 
collection and analysis required to complete the writing of the Report.
    Webinar/Conference Call: The webinar/conference call is scheduled 
for Wednesday, December 5, 2018, 9:00 a.m. to 10:00 a.m. (EST) and may 
end early if discussions are finished.
    Instructions to Participate in the Webinar/Conference Call on 
Wednesday, December 5, 2018: Please dial: (888) 949-2790; Pass Code: 
1989852
    Background Information on the Committee: The PCPID acts in an 
advisory capacity to the President and the Secretary of Health and 
Human Services on a broad range of topics relating to programs, 
services and support for individuals with intellectual disabilities. 
The PCPID executive order stipulates that the Committee shall: (1) 
Provide such advice concerning intellectual disabilities as the 
President or the Secretary of Health and Human Services may request; 
and (2) provide advice to the President concerning the following for 
people with intellectual disabilities: (A) Expanding employment 
opportunities; (B) connecting people to services; (C) supporting 
families and caregivers; (D) strengthening the networks; and (E) 
protecting rights and preventing abuse.

    Dated: November 15, 2018.
Julie Hocker,
Commissioner, Administration on Disabilities (AoD).
[FR Doc. 2018-25375 Filed 11-20-18; 8:45 am]
BILLING CODE 4154-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.